Clinical Trial Update: A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 multicohort trial evaluating toripalimab in combination with investigator-selected chemotherapy for advanced HER2-negative breast cancer; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Investigator-selected chemotherapy
• Toripalimab (Toripalimab)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Advanced Breast Cancer | Phase 2 | Status: RECRUITING